Virtual Medicinal Product (VMP) - Atomoxetine 30mg/5ml oral suspension
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Atomoxetine 30mg/5ml oral suspension | Start Date 19-07-2017 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- N06BA09
- BNF Codes
-
- BNF code 04040000
| Code | Start Date | End Date |
|---|---|---|
| 34664811000001101 | 19-07-2017 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Atomoxetine hydrochloride | Based on Base Substance | Atomoxetine | 6 mg | 1 ml |
Name
Atomoxetine hydrochloride
Basis of strength description
Based on Base Substance
BOSS
Atomoxetine
Strength and UOM (Nmr)
6
Strength and UOM (Dmr)
1
Parent Products
-
VTMAtomoxetine
-
VMP(Current) Atomoxetine 30mg/5ml oral suspension
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 ml |